Steinberg-Vorhoff, H.L.; Tropotel, A.; Theysohn, J.M.; Schaarschmidt, B.; Haubold, J.; Jeschke, M.; Jochheim, L.; Ludwig, J.M.
Evaluation of Inflammatory Markers as Prognostic Factors in the Treatment of Hepatocellular Carcinoma (HCC) with Degradable Starch Microspheres by Transarterial Chemoembolization (DSM-TACE). Cancers 2025, 17, 647.
https://doi.org/10.3390/cancers17040647
AMA Style
Steinberg-Vorhoff HL, Tropotel A, Theysohn JM, Schaarschmidt B, Haubold J, Jeschke M, Jochheim L, Ludwig JM.
Evaluation of Inflammatory Markers as Prognostic Factors in the Treatment of Hepatocellular Carcinoma (HCC) with Degradable Starch Microspheres by Transarterial Chemoembolization (DSM-TACE). Cancers. 2025; 17(4):647.
https://doi.org/10.3390/cancers17040647
Chicago/Turabian Style
Steinberg-Vorhoff, Hannah L., Andriana Tropotel, Jens M. Theysohn, Benedikt Schaarschmidt, Johannes Haubold, Matthias Jeschke, Leonie Jochheim, and Johannes M. Ludwig.
2025. "Evaluation of Inflammatory Markers as Prognostic Factors in the Treatment of Hepatocellular Carcinoma (HCC) with Degradable Starch Microspheres by Transarterial Chemoembolization (DSM-TACE)" Cancers 17, no. 4: 647.
https://doi.org/10.3390/cancers17040647
APA Style
Steinberg-Vorhoff, H. L., Tropotel, A., Theysohn, J. M., Schaarschmidt, B., Haubold, J., Jeschke, M., Jochheim, L., & Ludwig, J. M.
(2025). Evaluation of Inflammatory Markers as Prognostic Factors in the Treatment of Hepatocellular Carcinoma (HCC) with Degradable Starch Microspheres by Transarterial Chemoembolization (DSM-TACE). Cancers, 17(4), 647.
https://doi.org/10.3390/cancers17040647
